PetMed Express
PETS
127 hedge funds and large institutions have $180M invested in PetMed Express in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 17 closing their positions.
4% less capital invested
Capital invested by funds: $187M → $180M (-$6.57M)
10% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 41
2% less funds holding
Funds holding: 130 → 127 (-3)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
69% less call options, than puts
Call options by funds: $1.9M | Put options by funds: $6.12M
Top Buyers
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$3.57M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.64M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$2.26M |
| 4 |
Morgan Stanley
New York
|
+$1.92M |
| 5 |
Goldman Sachs
New York
|
+$1.87M |
Top Sellers
PETS Hedge Fund Activity: Q2 2014 in Review
127 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q2 2014, worth a combined $180M — down 3.5% from $187M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of PETS and 14 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 37 added.
The largest buyer was Allianz Asset Management, adding an estimated $3.57M. The largest seller was JP Morgan Chase, cutting an estimated $2.88M.
- 127 institutional investors held PetMed Express (PETS) as of Q2 2014, down from 130 in Q1 2014.
- Funds reported $180M of PetMed Express stock for Q2 2014, down 3.5% quarter-over-quarter.
- 14 funds opened new PetMed Express positions in Q2 2014 and 17 closed out, a net change of -3 holders.
- The largest PetMed Express buyer in Q2 2014 was Allianz Asset Management, an estimated $3.57M added.
- The largest PetMed Express seller in Q2 2014 was JP Morgan Chase, an estimated $2.88M sold.
Based on aggregated 13F filings for Q2 2014.